MedTrace Logo

Interleukin 33 in Juvenile Idiopathic Arthritis Patients

NCT03835624 · Status: COMPLETED · Type: OBSERVATIONAL · Enrollment: 120

Last updated 2019-12-11

No results posted yet for this study

Summary

The aim of this study is to measure serum and synovial fluid levels of IL 33 and its relative mRNA expression in peripheral blood mononuclear cells in juvenile idiopathic arthritis (JIA) patients and to correlate it with the clinical and laboratory characteristics, disease activity and musculoskeletal ultrasound findings.

Conditions

  • Juvenile Idiopathic Arthritis

Interventions

DIAGNOSTIC_TEST

interleukin 33

serum and synovial fluid samples will be obtained from patients and serum samples from controls to measure interleukin 33 and its relative mRNA expression in peripheral blood mononuclear cells by PCR

Sponsors & Collaborators

  • Benha University

    lead OTHER

Principal Investigators

  • Waleed Hassan, MD · Benha university- Qaluibya- Egypt

Eligibility

Max Age
16 Years
Sex
ALL
Healthy Volunteers
Yes

Timeline & Regulatory

Start
2019-02-12
Primary Completion
2019-11-20
Completion
2019-11-20

Countries

  • Egypt

Study Locations

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT03835624 on ClinicalTrials.gov